Get started
Author

Pippa Riddle

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial
2018 · Galina Velikova, Linda Jane Williams, et al. · The Lancet Oncology · 80
PDF
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial
2019 · Stuart A Taylor, Sue Mallett, et al. · The Lancet. Gastroenterology & hepatology · 75
PDF
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial
2019 · Stuart A Taylor, Sue Mallett, et al. · The Lancet Respiratory Medicine · 68
PDF
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer
2021 · R. Charles Coombes, Holly Tovey, et al. · JAMA Oncology · 51
PDF
Postoperative chemotherapy improves survival in patients with resected high‐risk Stage II colorectal cancer: results of a systematic review and meta‐analysis
2020 · C. Simillis, H. K. S. I. Singh, et al. · Colorectal Disease · 42
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom
2024 · Daire Hanna, Sophie Merrick, et al. · British Journal of Cancer · 39
PDF
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy
2012 · Kaiyumars Contractor, Amarnath Challapalli, et al. · Physics in Medicine and Biology · 19
Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome
2011 · Jonathan Krell, Colin R. James, et al. · Clinical Breast Cancer · 18
Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era
2011 · Carlo Palmieri, Deep Shah, et al. · Clinical Breast Cancer · 15
PDF
Acute myeloid leukaemia secondary to treatment with capecitabine for metastatic colorectal cancer
2007 · Susan Shapiro, George Hughes, et al. · European Journal Of Haematology · 10
PDF
Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer
2022 · Amit Bahl, William Wilson, et al. · The Breast · 8
PDF
Clinical evaluation of atlas-based auto-segmentation in breast and nodal radiotherapy
2023 · Camarie Welgemoed, Emiliano Spezi, et al. · British Journal of Radiology · 6
The HERPET study: Imaging HER2 expression in breast cancer with the novel PET tracer [18F]GE-226, a first-in-patient study.
2022 · Laura M. Kenny, Fiona J Gilbert, et al. · Journal of Clinical Oncology · 5
Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer
2015 · Carlo Palmieri, Iain RJ Macpherson, et al. · Oncotarget · 5
PDF
A dosimetric study to improve the quality of nodal radiotherapy in breast cancer
2021 · Camarie Welgemoed, Simon Coughlan, et al. · BJR|Open · 4
232P Real-world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom
2023 · D. Hanna, S. Merrick, et al. · ESMO Open · 3
PDF
Deep inspirational breath hold to reduce cardiac dose in left-sided breast radiotherapy
2017 · Camarie Welgemoed, Jonathan Rogers, et al. · Journal of Radiotherapy in Practice · 3
Randomized multicenter trial of 3 weekly cabazitaxel versus weekly paclitaxel chemotherapy in the first-line treatment of HER2 negative metastatic breast cancer (MBC).
2021 · Amit Bahl, Jeremy Braybrooke, et al. · Journal of Clinical Oncology · 2
913 Patient Satisfaction with Personalised Stratified Follow-Up After Treatment for Breast Cancer at West Middlesex University Hospital
2022 · S Arooj, L Elhadi, et al. · British journal of surgery · 1
PDF
PO-0934: Evaluation of nodal outlining based on ESTRO guidelines in breast radiotherapy planning
2020 · C. Welgemoed, E. Spezi, et al. · Radiotherapy and Oncology · 1
426P Cognitive impairment (chemobrain) in early breast cancer patients treated with anthracycline/taxane chemotherapy
2025 · L. Kenny, R. Vicidomini, et al. · ESMO Open
PDF
A paradigm shift in the neoadjuvant treatment of rectal cancer: a single-institution real-world cohort study using the COVID-19 pandemic to compare clinical outcomes between long-course chemoradiotherapy and RAPIDO-style total neoadjuvant therapy
2023 · Robert Kitson, Arabella Hunt, et al. · The Royal College of Radiologists Open
A Retrospective Analysis of the Dose-intensity and Toxicities of Accelerated Versus Standard-schedule Chemotherapy for Early Breast Cancer in a Real-world Setting
2020 · J.D. Towler, K. Ball, et al. · Clinical Oncology
A Phase I/ II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES)
2019 · Robert Glynne-Jones, Helen M Meadows, et al. · Archives of Clinical and Biomedical Research
PDF
Management of Bone Health in Breast Cancer Patients Established on Aromatase Inhibitors
2017 · K. Chan, W. Coomaraswamy, et al. · Clinical Oncology
Works count: 32
Citation count: 455
H-index: 10
I10-index: 10
Year
Topic
Type